These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Pathology of nonalcoholic steatohepatitis. Brunt EM Hepatol Res; 2005 Oct; 33(2):68-71. PubMed ID: 16214395 [TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Gerges SH; Wahdan SA; Elsherbiny DA; El-Demerdash E Life Sci; 2021 Apr; 271():119220. PubMed ID: 33592199 [TBL] [Abstract][Full Text] [Related]
14. Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. Sumida Y; Eguchi Y; Ono M World J Hepatol; 2010 Oct; 2(10):374-83. PubMed ID: 21160946 [TBL] [Abstract][Full Text] [Related]
15. Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. Masarone M; Troisi J; Aglitti A; Torre P; Colucci A; Dallio M; Federico A; Balsano C; Persico M Metabolomics; 2021 Jan; 17(2):12. PubMed ID: 33458794 [TBL] [Abstract][Full Text] [Related]
16. The diagnosis and treatment of non-alcoholic fatty liver disease. Altinbas A; Sowa JP; Hasenberg T; Canbay A Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905 [TBL] [Abstract][Full Text] [Related]
18. How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis. Henry ZH; Argo CK Gastroenterol Clin North Am; 2020 Mar; 49(1):45-62. PubMed ID: 32033764 [TBL] [Abstract][Full Text] [Related]
19. Promising therapies for treatment of nonalcoholic steatohepatitis. Noureddin M; Zhang A; Loomba R Expert Opin Emerg Drugs; 2016 Sep; 21(3):343-57. PubMed ID: 27501374 [TBL] [Abstract][Full Text] [Related]